Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine

Seminars in Cell and Developmental Biology

Volumn 23, Issue 6, 2012, Pages 701-710

  Nostro, Maria Cristina ^a   Keller, Gordon ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Beta cell; Diabetes; Directed differentiation; HESC; HiPSC

Indexed keywords

INSULIN;

CELL LINEAGE; CELL MATURATION; EMBRYONIC STEM CELL; HUMAN; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION;

MUS;

EID: 84865157730     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.06.010     Document Type: Review

References (93)

1. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002, 346:393-403.
2. Meloche R.M. Transplantation for the treatment of type 1 diabetes. World Journal of Gastroenterology 2007, 13:6347-6355.
3. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New England Journal of Medicine 2000, 343:230-238.
4. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060-2069.
5. Shapiro A.M., Ricordi C., Hering B.J., Auchincloss H., Lindblad R., Robertson R.P., et al. International trial of the Edmonton protocol for islet transplantation. New England Journal of Medicine 2006, 355:1318-1330.
6. Baiu D., Merriam F., Odorico J. Potential pathways to restore beta-cell mass: pluripotent stem cells, reprogramming, and endogenous regeneration. Current Diabetes Reports 2011, 11:392-401.
7. Chung C.H., Levine F. Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration. The Review of Diabetic Studies 2010, 7:124-131.
8. Collombat P., Xu X., Heimberg H., Mansouri A. Pancreatic beta-cells: from generation to regeneration. Seminars in Cell and Developmental Biology 2010, 21:838-844.
9. Sumi S. Regenerative medicine for insulin deficiency: creation of pancreatic islets and bioartificial pancreas. Journal of Hepato-Biliary-Pancreatic Sciences 2011, 18:6-12.
10. Yechoor V., Chan L. Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation. Molecular Endocrinology 2010, 24:1501-1511.
11. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
12. Wells J.M., Melton D.A. Vertebrate endoderm development. Annual Review of Cell and Developmental Biology 1999, 15:393-410.
13. Jorgensen M.C., Ahnfelt-Ronne J., Hald J., Madsen O.D., Serup P., Hecksher-Sorensen J. An illustrated review of early pancreas development in the mouse. Endocrine Reviews 2007, 28:685-705.
14. Murtaugh L.C. Pancreas and beta-cell development: from the actual to the possible. Development (Cambridge, England) 2007, 134:427-438.
15. Murtaugh L.C., Melton D.A. Genes, signals, and lineages in pancreas development. Annual Review of Cell and Developmental Biology 2003, 19:71-89.
16. Gu G., Brown J.R., Melton D.A. Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mechanisms of Development 2003, 120:35-43.
17. Gu G., Dubauskaite J., Melton D.A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129:2447-2457.
18. Kawaguchi Y., Cooper B., Gannon M., Ray M., MacDonald R.J., Wright C.V. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nature Genetics 2002, 32:128-134.
19. Kim S.K., MacDonald R.J. Signaling and transcriptional control of pancreatic organogenesis. Current Opinion in Genetics and Development 2002, 12:540-547.
20. Hald J., Sprinkel A.E., Ray M., Serup P., Wright C., Madsen O.D. Generation and characterization of Ptf1a antiserum and localization of Ptf1a in relation to Nkx6.1 and Pdx1 during the earliest stages of mouse pancreas development. Journal of Histochemistry and Cytochemistry 2008, 56:587-595.
21. Seymour P.A., Freude K.K., Tran M.N., Mayes E.E., Jensen J., Kist R., et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1865-1870.
22. Zhou Q., Law A.C., Rajagopal J., Anderson W.J., Gray P.A., Melton D.A. A multipotent progenitor domain guides pancreatic organogenesis. Developmental Cell 2007, 13:103-114.
23. Teitelman G., Alpert S., Polak J.M., Martinez A., Hanahan D. Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. Development 1993, 118:1031-1039.
24. Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000, 127:2317-2322.
25. Herrera P.L., Huarte J., Zufferey R., Nichols A., Mermillod B., Philippe J., et al. Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:12999-13003.
26. Sander M., Sussel L., Conners J., Scheel D., Kalamaras J., Dela Cruz F., et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 2000, 127:5533-5540.
27. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology 2006, 24:1392-1401.
28. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology 2008, 26:443-452.
29. Ameri J., Stahlberg A., Pedersen J., Johansson J.K., Johannesson M.M., Artner I., et al. FGF2 specifies hESC-derived definitive endoderm into foregut/midgut cell lineages in a concentration-dependent manner. Stem Cells 2010, 28:45-56.
30. Cai J., Yu C., Liu Y., Chen S., Guo Y., Yong J., et al. Generation of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm cells. Journal of Molecular Cell Biology 2009, 2:50-60.
31. Jiang J., Au M., Lu K., Eshpeter A., Korbutt G., Fisk G., et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007, 25:1940-1953.
32. Jiang W., Shi Y., Zhao D., Chen S., Yong J., Zhang J., et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Research 2007, 17:333-344.
33. Johannesson M., Stahlberg A., Ameri J., Sand F.W., Norrman K., Semb H. FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner. PLoS One 2009, 4:e4794.
34. Kunisada Y., Tsubooka-Yamazoe N., Shoji M., Hosoya M. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Research 2012 March, 8(2):274-284.
35. Mfopou J.K., Chen B., Mateizel I., Sermon K., Bouwens L., Noggin Retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Gastroenterology 2010 June, 138(7):2233-2245. 2245.e1-14.
36. Micallef S.J., Li X., Schiesser J.V., Hirst C.E., Yu Q.C., Lim S.M., et al. INS GFP/w insulin-producing cells. Diabetologia 2012 March, 55(3):694-706.
37. Nostro M.C., Sarangi F., Ogawa S., Holtzinger A., Corneo B., Li X., et al. Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 2011, 138:861-871.
38. Rezania A., Riedel M.J., Wideman R.D., Karanu F., Ao Z., Warnock G.L., et al. Production of functional glucagon-secreting alpha cells from human embryonic stem cells. Diabetes 2011 January, 60(1):239-247.
39. Xu X., Browning V.L., Odorico J.S. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mechanisms of Development 2011, 128:412-427.
40. Zhang D., Jiang W., Liu M., Sui X., Yin X., Chen S., et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Research 2009, 19:429-438.
41. Gadue P., Huber T.L., Paddison P.J., Keller G.M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:16806-16811.
42. Kubo A., Shinozaki K., Shannon J.M., Kouskoff V., Kennedy M., Woo S., et al. Development of definitive endoderm from embryonic stem cells in culture. Development 2004, 131:1651-1662.
43. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology 2005, 23:1534-1541.
44. McLean A.B., D'Amour K.A., Jones K.L., Krishnamoorthy M., Kulik M.J., Reynolds D.M., et al. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 2007, 25:29-38.
45. Gouon-Evans V., Boussemart L., Gadue P., Nierhoff D., Koehler C.I., Kubo A., et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nature Biotechnology 2006, 24:1402-1411.
46. Yasunaga M., Tada S., Torikai-Nishikawa S., Nakano Y., Okada M., Jakt L.M., et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nature Biotechnology 2005, 23:1542-1550.
47. Wang P., Rodriguez R.T., Wang J., Ghodasara A., Kim S.K. Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell 2011, 8:335-346.
48. Green M.D., Chen A., Nostro M.C., d'Souza S.L., Schaniel C., Lemischka I.R., et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nature Biotechnology 2011, 29:267-272.
49. Sherwood R.I., Jitianu C., Cleaver O., Shaywitz D.A., Lamenzo J.O., Chen A.E., et al. Prospective isolation and global gene expression analysis of definitive and visceral endoderm. Developmental Biology 2007, 304:541-555.
50. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
51. Ungrin M.D., Clarke G., Yin T., Niebrugge S., Nostro M.C., Sarangi F., et al. Rational bioprocess design for human pluripotent stem cell expansion and endoderm differentiation based on cellular dynamics. Biotechnology and Bioengineering 2012 April, 109(4):853-866.
52. Lowe L.A., Yamada S., Kuehn M.R. Genetic dissection of nodal function in patterning the mouse embryo. Development 2001, 128:1831-1843.
53. Lee M.A., Heasman J., Whitman M. Timing of endogenous activin-like signals and regional specification of the Xenopus embryo. Development 2001, 128:2939-2952.
54. Perea-Gomez A., Vella F.D., Shawlot W., Oulad-Abdelghani M., Chazaud C., Meno C., et al. Nodal antagonists in the anterior visceral endoderm prevent the formation of multiple primitive streaks. Developmental Cell 2002, 3:745-756.
55. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470:105-109.
56. Kinder S.J., Tsang T.E., Quinlan G.A., Hadjantonakis A.K., Nagy A., Tam P.P. The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development (Cambridge, England) 1999, 126:4691.
57. Kouskoff V., Lacaud G., Schwantz S., Fehling H.J., Keller G. Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13170.
58. Dessimoz J., Opoka R., Kordich J.J., Grapin-Botton A., Wells J.M. FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo. Mechanisms of Development 2006, 123:42-55.
59. McLin V.A., Rankin S.A., Zorn A.M. Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development 2007, 134:2207-2217.
60. Ye F., Duvillie B., Scharfmann R. Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells. Diabetologia 2005, 48:277-281.
61. Apelqvist A., Li H., Sommer L., Beatus P., Anderson D.J., Honjo T., et al. Notch signalling controls pancreatic cell differentiation. Nature 1999, 400:877-881.
62. Bhushan A., Itoh N., Kato S., Thiery J.P., Czernichow P., Bellusci S., et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001, 128:5109-5117.
63. Hart A., Papadopoulou S., Edlund H. Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells. Developmental Dynamics 2003, 228:185-193.
64. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., et al. Control of endodermal endocrine development by Hes-1. Nature Genetics 2000, 24:36-44.
65. Norgaard G.A., Jensen J.N., Jensen J. FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Developmental Biology 2003, 264:323-338.
66. Kelly O.G., Chan M.Y., Martinson L.A., Kadoya K., Ostertag T.M., Ross K.G., et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnology 2011, 29:750-756.
67. Spence J.R., Lange A.W., Lin S.C., Kaestner K.H., Lowy A.M., Kim I., et al. Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Developmental Cell 2009, 17:62-74.
68. Wandzioch E., Zaret K.S. Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science 2009, 324:1707-1710.
69. Rossi J.M., Dunn N.R., Hogan B.L., Zaret K.S. Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes and Development 2001, 15:1998-2009.
70. Bar-Nur O., Russ H.A., Efrat S., Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 2011, 9:17-23.
71. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
72. Osafune K., Caron L., Borowiak M., Martinez R.J., Fitz-Gerald C.S., Sato Y., et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology 2008, 26:313-315.
73. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology 2010, 28:848-855.
74. Kumar M., Jordan N., Melton D., Grapin-Botton A. Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Developmental Biology 2003, 259:109-122.
75. Martin M., Gallego-Llamas J., Ribes V., Kedinger M., Niederreither K., Chambon P., et al. Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant mice. Developmental Biology 2005, 284:399-411.
76. Molotkov A., Molotkova N., Duester G. Retinoic acid generated by Raldh2 in mesoderm is required for mouse dorsal endodermal pancreas development. Developmental Dynamics 2005, 232:950-957.
77. Stafford D., Prince V.E. Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development. Current Biology 2002, 12:1215-1220.
78. Hebrok M., Kim S.K., Melton D.A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes and Development 1998, 12:1705-1713.
79. Apelqvist A., Ahlgren U., Edlund H. Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Current Biology 1997, 7:801-804.
80. Chen S., Borowiak M., Fox J.L., Maehr R., Osafune K., Davidow L., et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nature Chemical Biology 2009, 5:258-265.
81. Maehr R., Chen S., Snitow M., Ludwig T., Yagasaki L., Goland R., et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:15768-15773.
82. Thatava T., Nelson T.J., Edukulla R., Sakuma T., Ohmine S., Tonne J.M., et al. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Therapy 2010, 18:283-293.
83. Gittes G.K. Developmental biology of the pancreas: a comprehensive review. Developmental Biology 2009, 326:4-35.
84. Lee J.C., Smith S.B., Watada H., Lin J., Scheel D., Wang J., et al. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 2001, 50:928-936.
85. Murtaugh L.C., Stanger B.Z., Kwan K.M., Melton D.A. Notch signaling controls multiple steps of pancreatic differentiation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14920-14925.
86. Bardeesy N., Cheng K.H., Berger J.H., Chu G.C., Pahler J., Olson P., et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes and Development 2006, 20:3130-3146.
87. Basford C.L., Prentice K.J., Hardy A.B., Sarangi F., Micallef S.J., Li X., et al. The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells. Diabetologia 2011, 55:358-371.
88. Jeon J., Correa-Medina M., Ricordi C., Edlund H., Diez J.A. Endocrine cell clustering during human pancreas development. Journal of Histochemistry and Cytochemistry 2009, 57:811-824.
89. Riedel M.J., Asadi A., Wang R., Ao Z., Warnock G.L., Kieffer T.J. Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas. Diabetologia 2011, 55:372-381.
90. Collombat P., Xu X., Ravassard P., Sosa-Pineda B., Dussaud S., Billestrup N., et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009, 138:449-462.
91. Chung C.H., Hao E., Piran R., Keinan E., Levine F. Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells 2010, 28:1630-1638.
92. Thorel F., Nepote V., Avril I., Kohno K., Desgraz R., Chera S., et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464:1149-1154.
93. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nature Biotechnology 2009, 27:275-280.